Intravitreal Interleukin 6 Inhibitors for Uveitic Macular Edema

This Viewpoint discusses the results of a phase 1 study evaluating the intravitreal interleukin 6 inhibitor vamikibart for the treatment of uveitic macular edema.

Authors

Institutions

Publication Details

Journal
JAMA Ophthalmology
Published
2026-04-30
DOI
https://doi.org/10.1001/jamaophthalmol.2026.1114
Primary Topic
Ocular Diseases and Behçet’s Syndrome
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Intravitreal Interleukin 6 Inhibitors for Uveitic Macular Edema

Stephanie M. Llop, Swati L Narayan
JAMA Ophthalmology
Ocular Diseases and Behçet’s Syndrome
article

Intravitreal Interleukin 6 Inhibitors for Uveitic Macular Edema

Stephanie M. Llop, Swati L Narayan
article en

Abstract

This Viewpoint discusses the results of a phase 1 study evaluating the intravitreal interleukin 6 inhibitor vamikibart for the treatment of uveitic macular edema.

JAMA Ophthalmology
Rutgers, The State University of New Jersey (US), University of Miami (US), Johnson University (US)
Zero hunger
Openalex Percentile: Top 8%
Ocular Diseases and Behçet’s Syndrome
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.